PVT1 and cancer: By considering that PVT1 was recently reported to be a enhancer of chemosensitivity in cancer cells, we used several agents with different mechanisms of action: direct DNA damage (carboplatin), DNA synthesis inhibition (5‐FU) or cell division disruption (paclitaxel).